drugset
drugset / Trial / NCT05033535

s086 Tablets in the Treatment of Mild to Moderate Essential Hypertension

NCT05033535 ↗

Phase 2 Unknown 10 enrolled Shenzhen People's Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

Efficacy and Safety of s086 Tablets in the Treatment of Mild to Moderate Essential Hypertension:a Randomized,Double-blind,Placebo-controlled,Multicenter Phase II Clinical Trial

Timeline

Start
2020-07-01
Primary completion
2021-12-01
Completion
2022-06-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Olmesartan medoxomil Unknown — —
Subject Sacubatril Allisartan medoxomil Unknown — —

Indications

essential hypertension